Dr. Daniel Curran is the senior vice president and head of the Center for External Innovation at Takeda Pharmaceuticals, Inc., where he oversees an annual budget of over $200 million, used to license and fund further development of pre-clinical and clinical candidates in disease areas such as heart disease, diabetes, and oncology.

Prior to his time at Takeda, Daniel lead the corporate development group at Millennium Pharmaceuticals, Inc., and was a member of the Millennium executive management team. In that role, he led the development and execution of corporate strategic business development initiatives. In full, he has 18 years of pharmaceutical experience in business development, project leadership, and development roles.

After graduating with a Bachelor of Science in chemistry from King’s College, PA, Daniel attended the University of Pennsylvania, where he received a master’s in business administration. In 1991, he obtained an M.D. from the Pennsylvania School of Medicine.

He lives in Massachusetts with his wife and four children.